BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18727636)

  • 21. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.
    Hillmer AT; Wooten DW; Bajwa AK; Higgins AT; Lao PJ; Betthauser TJ; Barnhart TE; Rowley HA; Stone CK; Johnson SC; Mukherjee J; Christian BT
    J Nucl Med; 2014 Dec; 55(12):1973-9. PubMed ID: 25453045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
    Saigal N; Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2006 Oct; 47(10):1697-706. PubMed ID: 17015907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies.
    Laćan G; Plenevaux A; Rubins DJ; Way BM; Defraiteur C; Lemaire C; Aerts J; Luxen A; Cherry SR; Melega WP
    Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2256-66. PubMed ID: 18604533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroPET imaging of 5-HT 1A receptors in rat brain: a test-retest [18F]MPPF study.
    Aznavour N; Benkelfat C; Gravel P; Aliaga A; Rosa-Neto P; Bedell B; Zimmer L; Descarries L
    Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):53-62. PubMed ID: 18704404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.
    Tauscher J; Kapur S; Verhoeff NP; Hussey DF; Daskalakis ZJ; Tauscher-Wisniewski S; Wilson AA; Houle S; Kasper S; Zipursky RB
    Arch Gen Psychiatry; 2002 Jun; 59(6):514-20. PubMed ID: 12044193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased serotonin receptor availability in human sleep: evidence from an [18F]MPPF PET study in narcolepsy.
    Derry C; Benjamin C; Bladin P; le Bars D; Tochon-Danguy H; Berkovic SF; Zimmer L; Costes N; Mulligan R; Reutens D
    Neuroimage; 2006 Apr; 30(2):341-8. PubMed ID: 16275016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF.
    Passchier J; van Waarde A; Pieterman RM; Elsinga PH; Pruim J; Hendrikse HN; Willemsen AT; Vaalburg W
    J Nucl Med; 2000 Nov; 41(11):1830-5. PubMed ID: 11079490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A PET imaging study of 5-HT(1A) receptors in cat brain after acute and chronic fluoxetine treatment.
    Aznavour N; Rbah L; Riad M; Reilhac A; Costes N; Descarries L; Zimmer L
    Neuroimage; 2006 Nov; 33(3):834-42. PubMed ID: 16996750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothalamic serotonin-1A receptor binding measured by PET predicts the plasma level of dehydroepiandrosterone sulfate in healthy women.
    Moser U; Wadsak W; Spindelegger C; Mitterhauser M; Mien LK; Bieglmayer C; Kletter K; Kasper S; Lanzenberger R
    Neurosci Lett; 2010 Jun; 476(3):161-5. PubMed ID: 20399839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.
    Jovanovic H; Lundberg J; Karlsson P; Cerin A; Saijo T; Varrone A; Halldin C; Nordström AL
    Neuroimage; 2008 Feb; 39(3):1408-19. PubMed ID: 18036835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection.
    Costes N; Merlet I; Zimmer L; Lavenne F; Cinotti L; Delforge J; Luxen A; Pujol JF; Le Bars D
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):753-65. PubMed ID: 12045674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of aripiprazole, risperidone, and olanzapine on 5-HT1A receptors in patients with schizophrenia.
    Lerond J; Lothe A; Ryvlin P; Bouvard S; d'Amato T; Ciumas C; Daléry J; Poulet E; Saoud M
    J Clin Psychopharmacol; 2013 Feb; 33(1):84-9. PubMed ID: 23277246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats.
    Defraiteur C; Lemaire C; Luxen A; Plenevaux A
    Nucl Med Biol; 2006 Jul; 33(5):667-75. PubMed ID: 16843842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wide impairment of cerebral serotoninergic activity but inter-individual heterogeneity in bulimia nervosa patients: a pilot [(18)F]MPPF/PET study.
    Galusca B; Sigaud T; Costes N; Redoute J; Massoubre C; Estour B
    World J Biol Psychiatry; 2014 Dec; 15(8):599-608. PubMed ID: 25054914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using cerebral white matter for estimation of nondisplaceable binding of 5-HT1A receptors in temporal lobe epilepsy.
    Giovacchini G; Conant S; Herscovitch P; Theodore WH
    J Nucl Med; 2009 Nov; 50(11):1794-800. PubMed ID: 19837769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the quantification of [18F]MPPF binding to 5-HT1A receptors in the human brain.
    Passchier J; van Waarde A; Vaalburg W; Willemsen AT
    J Nucl Med; 2001 Jul; 42(7):1025-31. PubMed ID: 11438622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parametric mapping of 5HT1A receptor sites in the human brain with the Hypotime method: theory and normal values.
    Møller M; Rodell A; Gjedde A
    J Nucl Med; 2009 Aug; 50(8):1229-36. PubMed ID: 19617338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET.
    Tauscher J; Verhoeff NP; Christensen BK; Hussey D; Meyer JH; Kecojevic A; Javanmard M; Kasper S; Kapur S
    Neuropsychopharmacology; 2001 May; 24(5):522-30. PubMed ID: 11282252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral depression and positron emission tomography-determined serotonin 1A receptor binding potential in cynomolgus monkeys.
    Shively CA; Friedman DP; Gage HD; Bounds MC; Brown-Proctor C; Blair JB; Henderson JA; Smith MA; Buchheimer N
    Arch Gen Psychiatry; 2006 Apr; 63(4):396-403. PubMed ID: 16585468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer disease.
    Lanctôt KL; Hussey DF; Herrmann N; Black SE; Rusjan PM; Wilson AA; Houle S; Kozloff N; Verhoeff NP; Kapur S
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):888-98. PubMed ID: 17567932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.